Welcome to The Pharmacogenomics Journal

The Pharmacogenomics Journal is dedicated to the rapid publication of original research on basic pharmacogenomics research and its clinical applications. Publishing six times a year, the journal aims to provide the highest caliber of coverage concerning the effects of genetic variablity on drug toxicity and efficacy, the characterization of polymorphisms relevant to drug action, and the identification of novel genomic targets for drug development.

Looking for more information on pharmacogenomics? Read about its scope, limitations and applications in this article, featuring The Pharmacogenomics Journal's own Julio Licinio.

NEW FROM NATURE PUBLISHING GROUP: Translational Psychiatry
Editor-in-Chief: Julio Licinio, MD

Translational Psychiatry, a sister journal to Molecular Psychiatry, is a new online-only, open access publication that provides high quality research, a respected editorial team, rapid publication and high visibility. Submit your research today! Visit www.nature.com/tp/.

*** Announcing Open Access publication option ***

The Pharmacogenomics Journal now offers authors the option to publish their articles with immediate open access upon publication. Open access articles will also be deposited on PubMed Central at the time of publication and will be freely available immediately. Find out more from the press release or our FAQs page.